78 Participants Needed

Video-logs for HIV Prevention

(PrEP Trial)

MH
Overseen ByMandy Hill, Dr.PH, MPH, HIVPCP
Age: 18+
Sex: Female
Trial Phase: Phase < 1
Sponsor: The University of Texas Medical Branch, Galveston
Must be taking: PrEP
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on increasing willingness to start PrEP among participants.

What data supports the effectiveness of the Video-log (vlog) series treatment for HIV prevention?

Research shows that video-based interventions, like smartphone-delivered videos, are acceptable and engaging for people in HIV prevention programs. Additionally, technology-based interventions, such as videophone sessions, have been effective in improving medication adherence in people living with HIV.12345

Is there any safety data available for the Video-log series used in HIV prevention trials?

The research articles provided do not contain specific safety data for the Video-log series or similar interventions in HIV prevention trials.678910

How does the Video-logs for HIV Prevention treatment differ from other HIV prevention methods?

The Video-logs for HIV Prevention treatment is unique because it uses video-based interventions delivered via smartphones or handheld devices to educate and reduce HIV risk, making it accessible and engaging for users. This approach leverages technology to provide real-time, personalized education, which is different from traditional methods that may not utilize digital platforms.15111213

What is the purpose of this trial?

The primary objective of this R34 proposal is to increase willingness for PrEP initiation and PrEP initiation among Cisgender Black Women (CBW) and increase willingness to prescribe/refer pre-exposure prophylaxis (PrEP) to CBW among healthcare providers (HCPs) in Houston/Harris County, a high priority Ending the HIV Epidemic (EHE) jurisdiction.

Research Team

MH

Mandy Hill, DrPH,MPH,HIVPCP

Principal Investigator

University of Texas Medical Branch, Galveston

Eligibility Criteria

This trial is for cisgender Black women in Houston/Harris County interested in HIV prevention, and healthcare providers willing to prescribe/refer PrEP. Specific eligibility criteria are not detailed here.

Inclusion Criteria

I was assigned female at birth.
Participants in the category for CBW must be PrEP-eligible according to CDC criteria
Participants in the category for CBW must be fluent in English
See 2 more

Exclusion Criteria

Participants (i.e., PrEP-eligible CBW) must not be ineligible for PrEP
Participants (i.e., PrEP-eligible CBW) must not be unable or unwilling to meet study requirements
Participants (i.e., PrEP-eligible CBW) must not be unable to provide informed consent/assent for participation (i.e., have severe cognitive impairment that would interfere with their ability to consent or understand study procedures)
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants will watch a health-informed video-log series and complete a second survey (post-test)

6 months
Baseline, 1-month, 3-month, and 6-month visits

Follow-up

Participants are monitored for willingness to access/use PrEP and adherence to PrEP regimen

6 months
1-month, 3-month, and 6-month follow-up visits

Treatment Details

Interventions

  • Video-log (vlog) series
Trial Overview The study tests whether video logs (vlogs) tailored to either the women or their healthcare providers can increase willingness and actual initiation of PrEP for HIV prevention.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants will watch a health-informed video-log series and complete a second survey (post-test). The post-test will assess the same variables previously assessed in the pre-test.
Group II: Standard of CareActive Control1 Intervention
Participant will receive SOC and complete the post-test.

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Medical Branch, Galveston

Lead Sponsor

Trials
263
Recruited
55,400+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

A video-based smartphone intervention for HIV risk reduction was developed and found to be acceptable and feasible among 24 individuals in an addiction treatment clinic, with high satisfaction ratings and minimal technical issues.
The intervention may enhance knowledge about HIV and STD risk reduction, but further studies with pre-assessments and random assignments are necessary to validate these initial findings.
Smartphone Delivery of Mobile HIV Risk Reduction Education.Phillips, KA., Epstein, DH., Mezghanni, M., et al.[2022]
A systematic review of literature from 2013-2014 identified 23 published studies and 32 funded projects utilizing eHealth and mHealth strategies to enhance HIV prevention and care, indicating a growing trend in using technology for health interventions.
Despite the effective use of social media and other digital tools in engaging populations for HIV prevention, significant gaps still exist in ensuring patients are linked to care, retained in care, and initiated on antiretroviral therapy.
A systematic review of recent smartphone, Internet and Web 2.0 interventions to address the HIV continuum of care.Muessig, KE., Nekkanti, M., Bauermeister, J., et al.[2022]
A case study of a 54-year-old man with HIV showed that using videophone technology for adherence intervention significantly improved his medication adherence to 97.9% after eight sessions.
As a result of the intervention, the patient also experienced a considerable reduction in negative side effects from his HIV treatment, highlighting the potential benefits of remote adherence support.
A Fluctuating Pattern of Over- and Under-Adherence for HAART: A Case Study from a Videophone Intervention Project.Skrajner, MJ., Camp, CJ., Heckman, TG., et al.[2021]

References

Smartphone Delivery of Mobile HIV Risk Reduction Education. [2022]
A systematic review of recent smartphone, Internet and Web 2.0 interventions to address the HIV continuum of care. [2022]
A Fluctuating Pattern of Over- and Under-Adherence for HAART: A Case Study from a Videophone Intervention Project. [2021]
The Feasibility and Acceptability of Using Technology-Based Daily Diaries with HIV-Infected Young Men Who have Sex with Men: A Comparison of Internet and Voice Modalities. [2018]
A daily web diary of the sexual experiences of men who have sex with men: comparisons with a retrospective recall survey. [2022]
Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials. [2019]
Designing & Conducting Trials To Reliably Evaluate HIV Prevention Interventions. [2022]
Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention Modalities. [2023]
Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials. [2021]
Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019. [2022]
Educational technologies and practices for prevention of vertical HIV transmission. [2019]
12.United Statespubmed.ncbi.nlm.nih.gov
Soap opera video on handheld computers to reduce young urban women's HIV sex risk. [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
"Is Your Man Stepping Out?" An Online Pilot Study to Evaluate Acceptability of a Guide-Enhanced HIV Prevention Soap Opera Video Series and Feasibility of Recruitment by Facebook Advertising. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security